Singular Genomics Systems Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Singular Genomics Systems Inc. | OMIC - NASDAQ |
$20.00-$22.00 | $22.00 | $29.00 | 10.2 million | 5/27/2021 |
| JP Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-05-07 Terms Added 2021-05-24 | ||||||
Singular Genomics Systems Inc. Quote & Chart - Click for current quote - OMIC
IPO Boutique aggregates information on public companies and private companies, such as "OMIC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Singular Genomics Systems Inc. (adapted from Singular Genomics Systems Inc. prospectus):
They are a life science technology company that is leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a life science technology company that is leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "OMIC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.